Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-08-28 00:00:00 ET · period of report 2023-08-25 · accession 0001062993-23-017146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-28 | 2023-08-25 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $93.38 | +49.1K | 370.7K | +15% | +$4.58M |
| DM | 2023-08-28 | 2023-08-25 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | F - Tax | $381.78 | -30.4K | 345.3K | -8% | -$11.60M |
| DM | 2023-08-28 | 2023-08-25 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $0.00 | -49.1K | 6,245 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-08-25 | M | A | 2,081 | $0.00 | 429,925 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2023-08-25 | F | D | 1,032 | $381.78 | 428,893 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2023-08-25 | M | A | 1,266 | $0.00 | 430,159 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 4 | Common | Bio-Rad A Common Stock | 2023-08-25 | F | D | 628 | $381.78 | 429,531 | D | — | — | |
| 5 | Common | Bio-Rad A Common Stock | 2023-08-25 | M | A | 1,805 | $0.00 | 431,336 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 6 | Common | Bio-Rad A Common Stock | 2023-08-25 | F | D | 895 | $381.78 | 430,441 | D | — | — | |
| 7 | Common | Bio-Rad A Common Stock | 2023-08-25 | M | A | 2,320 | $0.00 | 432,761 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 8 | Common | Bio-Rad A Common Stock | 2023-08-25 | F | D | 1,151 | $381.78 | 431,610 | D | — | — | |
| 9 | Common | Bio-Rad A Common Stock | 2023-08-25 | M | A | 2,600 | $0.00 | 434,210 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 10 | Common | Bio-Rad A Common Stock | 2023-08-25 | F | D | 1,290 | $381.78 | 432,920 | D | — | — | |
| 11 | Common | Bio-Rad B Common Stock | 2023-08-25 | M | A | 39,000 | $117.50 | 370,689 | D | — | — | |
| 12 | Common | Bio-Rad B Common Stock | 2023-08-25 | F | D | 25,389 | $381.78 | 345,300 | D | — | — | |
| 13 | Derivative | Restricted Stock Units | 2023-08-25 | M | D | 1,805 | $0.00 | 1,805 | D | $0.00 · — to — | 1,805 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments, of which 1,805 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-08-25 | M | D | 39,000 | $0.00 | 0 | D | $117.50 · — to 2023-09-11 | 39,000 Bio-Rad B Common Stock | (F10) The option, representing a right to purchase a total of 39,000 shares, became exercisable in five equal annual installments beginning on September 11, 2014, which was the first anniversary of the date on which the option was granted. |
| 15 | Derivative | Restricted Stock Units | 2023-08-25 | M | D | 2,600 | $0.00 | 0 | D | $0.00 · — to — | 2,600 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F9) On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments, of which 2,600 vested on August 25, 2023. |
| 16 | Derivative | Restricted Stock Units | 2023-08-25 | M | D | 2,320 | $0.00 | 2,320 | D | $0.00 · — to — | 2,320 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F8) On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments, of which 2,320 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. |
| 17 | Derivative | Restricted Stock Units | 2023-08-25 | M | D | 1,266 | $0.00 | 2,532 | D | $0.00 · — to — | 1,266 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments, of which 1,266 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. |
| 18 | Derivative | Restricted Stock Units | 2023-08-25 | M | D | 2,081 | $0.00 | 6,245 | D | $0.00 · — to — | 2,081 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments, of which 2,081 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant. |